RGNX Earnings

Quarterly EPS
$-1.17
Q3 2024
$-1.01
Q4 2024
$0.12
Q1 2025
$-1.38
Q2 2025
$-1.20
Q3 2025
$-1.30
Q4 2025
$-1.72
Q1 2026
$0.43
Q2 2026
Latest Revenue108.0M
Latest Net Income22.7M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.43108.0M22.7M+405.7%+131.2%
Q1 2026-$1.726.4M-90051000-92.8%-1,533.3%
Q4 2025-$1.3030.3M-67149000+43.0%-28.7%
Q3 2025-$1.2029.7M-61941000+22.9%-2.6%
Q2 2025-$1.3821.4M-70871000-4.2%-31.4%
Q1 2025$0.1289.0M6.1M+469.8%+108.7%
Q4 2024-$1.0121.2M-51186000-4.5%+29.4%
Q3 2024-$1.1724.2M-59597000-16.3%+17.0%
Q2 2024-$1.0522.3M-52989000
Q1 2024-$1.3815.6M-63330000
Q4 2023-$1.4322.2M-62889000
Q3 2023-$1.4128.9M-61868000
REGENXBIO (RGNX) — Earnings